KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,012 | -40.0% | 31,008 | -0.8% | 0.00% | – |
| Q2 2023 | $718,711 | -30.7% | 31,262 | -10.7% | 0.00% | – |
| Q1 2023 | $1,037,495 | +25.4% | 35,015 | +5.6% | 0.00% | – |
| Q4 2022 | $827,524 | +16.1% | 33,154 | +1.3% | 0.00% | – |
| Q3 2022 | $713,000 | +26.2% | 32,730 | +14.0% | 0.00% | – |
| Q2 2022 | $565,000 | -53.0% | 28,703 | +0.9% | 0.00% | – |
| Q1 2022 | $1,203,000 | +38.3% | 28,445 | +107.6% | 0.00% | – |
| Q4 2021 | $870,000 | +10.5% | 13,700 | +2.3% | 0.00% | – |
| Q3 2021 | $787,000 | +142.9% | 13,395 | +100.6% | 0.00% | – |
| Q2 2021 | $324,000 | +383.6% | 6,678 | +287.8% | 0.00% | – |
| Q1 2021 | $67,000 | -38.5% | 1,722 | -1.4% | 0.00% | – |
| Q4 2020 | $109,000 | – | 1,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |